Financing type: at-the-market prospectus offering
Gross proceeds: $9,259,538 (U.S.) in the quarter ended Sept. 30, 2025, on the New York Stock Exchange
Offering: 3,557,500 common listed shares sold on the NYSE
Offering price: an average price of $2.60 (U.S.) per listed share on the NYSE
Disclosure: Refer to the prospectuses dated May 26, 2023, and July 26, 2023, as well as the prospectus supplement dated Nov. 15, 2023, and the company's news releases dated Nov. 17, 2023, April 12, 2024, July 5, 2024, Jan. 10, 2025, April 11, 2025, July 4, 2025, and Oct. 3, 2025.
© 2025 Canjex Publishing Ltd. All rights reserved.